Dixon Hubard Feinour & Brown’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $379K | Hold |
5,732
| – | – | 0.05% | 215 |
|
|
2022
Q1 | $380K | Hold |
5,732
| – | – | 0.04% | 240 |
|
|
2021
Q4 | $334K | Buy |
5,732
+250
| +5% | +$14.6K | 0.03% | 251 |
|
|
2021
Q3 | $329K | Buy |
5,482
+218
| +4% | +$13.1K | 0.07% | 142 |
|
|
2021
Q2 | $315K | Sell |
5,264
-8,771
| -62% | -$525K | 0.07% | 148 |
|
|
2021
Q1 | $742K | Buy |
14,035
+5,350
| +62% | +$283K | 0.09% | 130 |
|
|
2020
Q4 | $476K | Hold |
8,685
| – | – | 0.12% | 106 |
|
|
2020
Q3 | $476K | Buy |
8,685
+2,675
| +45% | +$147K | 0.12% | 106 |
|
|
2020
Q2 | $338K | Buy |
6,010
+1,110
| +23% | +$62.4K | 0.09% | 126 |
|
|
2020
Q1 | $219K | Hold |
4,900
| – | – | 0.07% | 145 |
|
|
2019
Q4 | $244K | Hold |
4,900
| – | – | 0.06% | 157 |
|
|
2019
Q3 | $218K | Hold |
4,900
| – | – | 0.06% | 162 |
|
|
2019
Q2 | $202K | Buy |
+4,900
| New | +$202K | 0.06% | 169 |
|
|
2015
Q2 | – | Sell |
-6,800
| Closed | -$233K | – | 187 |
|
|
2015
Q1 | $233K | Sell |
6,800
-128
| -2% | -$4.39K | 0.07% | 174 |
|
|
2014
Q4 | $244K | Hold |
6,928
| – | – | 0.08% | 169 |
|
|
2014
Q3 | $247K | Hold |
6,928
| – | – | 0.08% | 164 |
|
|
2014
Q2 | $257K | Hold |
6,928
| – | – | 0.08% | 161 |
|
|
2014
Q1 | $225K | Buy |
+6,928
| New | +$225K | 0.08% | 172 |
|